Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Clinical and Translational Science|October 31, 2019
Itraconazole Increases Ibrutinib Exposure 10-Fold and Reduces Interindividual Variation-A Potentially Beneficial Drug-Drug InteractionTuija Tapaninen, Aleksi M Olkkola, Aleksi Tornio, et al.
Anesthesia and Analgesia|September 21, 2023
Influence of Intravenous S-Ketamine on the Pharmacokinetics of Oral Morphine in Healthy VolunteersTerhi J Lohela, Satu Poikola, Daniel Backmansson, et al.
Pharmacogenetics and Genomics|January 15, 2008
Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphismsSamuel Fanta, Mikko Niemi, Siv Jönsson, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 9, 2017
Using Hilbert-Huang Transform to assess EEG slow wave activity during anesthesia in post-cardiac arrest patientsJukka Kortelainen, Eero Vayrynen, Usko Huuskonen, et al.
Anesthesiology|October 18, 2016
Pilot Study of Propofol-induced Slow Waves as a Pharmacologic Test for Brain Dysfunction after Brain InjuryJukka Kortelainen, Eero Väyrynen, Usko Huuskonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 3, 2019
Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8Helinä Kahma, Anne M Filppula, Terhi Launiainen, et al.
British Journal of Clinical Pharmacology|November 7, 2012
Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjectsMikko T Holmberg, Aleksi Tornio, Lotta Joutsi-Korhonen, et al.
Clinical Pharmacology and Therapeutics|April 17, 2019
Enantiospecific Pharmacogenomics of FluvastatinPäivi Hirvensalo, Aleksi Tornio, Mikko Neuvonen, et al.
Pharmacogenetics and Genomics|April 24, 2009
Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humansXiaoqiang Xiang, Yi Han, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|July 13, 2018
CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or PrasugrelMikko T Holmberg, Aleksi Tornio, Maria Paile-Hyvärinen, et al.
Pageof 16